STOCK TITAN

EVIO, Inc. Provides Shareholder Update on Current Company Priorities

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Tags

HENDERSON, NV / ACCESSWIRE / November 30, 2022 / EVIO, Inc. (OTC:EVIO) is pleased to provide an update on the process to become a fully reporting and audited firm.

The Company is currently in the process of completing its annual financial report for the period that ended on September 30, 2022 which is due December 30, 2022. The completion of the annual report is necessary to remain current with the OTC's alternate reporting regulations and avoid the Grey Market Status. Upon submission, the company fully intends to satisfy the OTCPink status for OTC Markets. Furthermore, the Company is committed to filing its quarterly reports with OTC Markets to remain in compliance until it becomes fully reporting with the SEC.

"Spotlight Media Corp (OTC:PSYC) is working with EVIO to become current and compliant with OTC Markets, FINRA, and the SEC," said EVIO CEO William Waldrop. "Pragmatic expectations for the next three-to-six months are completing the 2022 annual report to stay on the OTCPink and completing the necessary SEC audits prior to ultimately up-listing to the OTCQB."

EVIO is in the middle of a major transition, and management is focused on maximizing value for shareholders. During the last month, the Company executed on a previously announced strategy to cut costs and reduce dilution. The Company entered into a Warrant Cancellation agreement with one of its lenders, at the current time the Company has no outstanding warrants or options. After executing on a series of important growth initiatives, the core business fundamentals are better positioned in the near-term, and management will be providing updates on the process as needed.

About EVIO

EVIO, Inc. ("EVIO") is a diversified holding company, focused on Construction Services and Pharmaceutical Testing. In Florida, the Company offers general contractor services serving the residential and commercial construction industry. In Canada, via its ownership in Keystone, the Company provides pharmaceutical, environmental, stability and analytical testing.

Safe Harbor Statement

Any statements in this press release that are not statements of historical fact may be considered forward-looking statements pertaining to anticipated or projected plans, performance, and developments, as well as other statements relating to future operations and results. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only, and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, the Company's ability to complete product testing and launch product commercially, the acceptance of product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in Company reports available at www.evioinc.com.

For more information:
EVIO Inc.
William Waldrop, CEO
Email: info@evioinc.com
Phone (702) 748-9944

SOURCE: EVIO, Inc.



View source version on accesswire.com:
https://www.accesswire.com/729443/EVIO-Inc-Provides-Shareholder-Update-on-Current-Company-Priorities

EVIO, Inc.

OTC:EVIO

EVIO Rankings

EVIO Latest News

EVIO Stock Data

18.28k
10.12B
Testing Laboratories
Professional, Scientific, and Technical Services
Link
United States of America
Henderson

About EVIO

evio inc., (otcqb: evio) dba evio labs is the nation’s leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. evio labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation’s cannabis supply. evio labs has performed over 50,000 tests during the past two years and grown from one laboratory in oregon to eleven labs spanning 5 states and canada. evio labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. evio labs operates as an ancillary service provider, whereas we don't touch the plant, operate as a compliance agency for the states, and we are focused on developing cannabis solutions improving overall quality of life. the labs specialize in performing the following tests: • cannabinoid analysis, which properly characterizes the many primary c